DNA methyltransferase 3A (DNMT3A) and ten-eleven translocation methylcytosine dioxygenase 2 (TET2) are mutated in ~20% and ~10% of AML cases, respectively1. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.